# International Flavors & Fragrances Inc. – Consensus ‘buy’ rating and -1.3% Downside Potential

- Link: https://www.directorstalkinterviews.com/international-flavors-fragrances-inc.consensus-buy-rating-and-1.3-downside-potential/4121159785
- Published: 2024-06-11T14:43:44+01:00
- Author: Charlotte Edwards

**International Flavors & Fragrances Inc.** with ticker code (IFF) have now 20 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The target
price High/Low ranges between $116.00 and $70.00 suggesting an average Analsyt target
price of $97.16. Given that the stocks previous close was at $98.48 this would imply
there is a potential downside of -1.3%. It’s also worth noting that there is a 50
day moving average of $90.59 while the 200 day moving average is $78.82. The company
has a market cap of 24.71B. The current share price for the company is: $96.77 USD

 The potential market cap would be $24,379,105,460 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $44.51 and
a 1.19% return on assets.

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage,
health and biosciences, scent and pharma solutions and complementary adjacent products.
The Company’s segments include Nourish, Health & Biosciences, Scent and Pharma Solutions.
The Nourish segment comprises of ingredients, flavors and food designs, with a diversified
portfolio across natural and plant-based specialty food ingredients, flavor compounds,
and savory solutions and inclusions. The Health & Biosciences comprises of health,
cultures and food enzymes, home and personal care, animal nutrition and grain processing.
The Scent segment comprises of fragrance compounds, including fine fragrances and
consumer fragrances; fragrance ingredients, and cosmetic active ingredients. The
Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-
based pharmaceutical excipients, used to improve the functionality and delivery 
of active pharmaceutical ingredients.

Share on: